These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 3927648

  • 21. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
    Natori S, Iguchi H, Ohashi M, Kitamoto T, Chrétien M, Nawata H.
    Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion.
    Serri O.
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):675-82. PubMed ID: 2901301
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly.
    Nakagawa K, Akikawa K, Matsubara M, Kubo M.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458
    [Abstract] [Full Text] [Related]

  • 26. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A, Merola B, Ferone D, Calabrese MR, Longobardi S, Spaziante R, Di Renzo G, Annunziato L, Lombardi G.
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ, Liuzzi A.
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.
    Penny ES, Penman E, Price J, Rees LH, Sopwith AM, Wass JA, Lytras N, Besser GM.
    Br Med J (Clin Res Ed); 1984 Aug 25; 289(6443):453-5. PubMed ID: 6432140
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation.
    Hofland LJ, van Koetsveld PM, Verleun TM, Lamberts SW.
    Acta Endocrinol (Copenh); 1989 Aug 25; 121(2):270-8. PubMed ID: 2549755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.